Evidence map›Paper›PMID 17565699›Full record

ArticleRetrovirology2007

Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.

Emmanuel T Agbottah, Christine Traviss, James McArdle, Sambhav Karki, Georges C St Laurent, Ajit Kumar

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emmanuel T AgbottahDepartment of Biochemistry & Molecular Biology, School of Medicine, The George Washington University, Washington, DC, USA. bcmeta@gwumc.edu
Christine Traviss
James McArdle
Sambhav Karki
Georges C St Laurent
Ajit Kumar
George Washington University · US

Funding

Induction of Interferon to Block HIV-1 ReplicationR21AI054222 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KUMAR, AJIT NONE · 2003 to 2004
$456k
NIAID NIH HHS AI 054222NIAID NIH HHS R21 AI054222
6 · The paper itself

Abstract

backgroundExamination of host cell-based inhibitors of HIV-1 transcription may be important for attenuating viral replication. We describe properties of a cellular double-stranded RNA binding protein with intrinsic affinity for HIV-1 TAR RNA that interferes with Tat/TAR interaction and inhibits viral gene expression.

resultsUtilizing TAR affinity fractionation, North-Western blotting, and mobility-shift assays, we show that the C-terminal variant of nuclear factor 90 (NF90ctv) with strong affinity for the TAR RNA, competes with Tat/TAR interaction in vitro. Analysis of the effect of NF90ctv-TAR RNA interaction in vivo showed significant inhibition of Tat-transactivation of HIV-1 LTR in cells expressing NF90ctv, as well as changes in histone H3 lysine-4 and lysine-9 methylation of HIV chromatin that are consistent with the epigenetic changes in transcriptionally repressed gene.

conclusionStructural integrity of the TAR element is crucial in HIV-1 gene expression. Our results show that perturbation Tat/TAR RNA interaction by the dsRNA binding protein is sufficient to inhibit transcriptional activation of HIV-1.

Indexed as

Transcriptional ActivationBinding SitesCell FractionationCell LineElectrophoretic Mobility Shift AssayGene Products, tatHeLa CellsHistonesHIV-1HIV Long Terminal RepeatHumansJurkat CellsMethylationNuclear Factor 90 ProteinsProtein BindingRNA-Binding ProteinsGene Products, tatHistonesNuclear Factor 90 ProteinsRNA-Binding ProteinsRNA, Double-StrandedRNA, Viraltat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID17565699
PMCPMC1910605
OpenAlexW2133896397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.